Blood pressure response to antihypertensive agents related to baseline blood pressure

Journal of the Medical Association of Thailand

Volumn 85, Issue 10, 2002, Pages 1113-1120

  Sermswan, Anawat ^a   Suthichaiyakul, Tavorn ^c   Buranakitcharoen, Peera ^e   Uboldejpracharak, Yingnoi ^b   Sukontasarn, Apichart ^d  

^a NAVAMINDRADHIRAJ UNIVERSITY   (Thailand)

^b PRAMONGKUTKLAO HOSPITAL   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d Faculty of Medicine Chiang Mai University   (Thailand)

^e MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Ambulatory Blood Pressure Monitoring; Amlodipine; Hypertension; Mibefradil; White Coat Hypertension

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; MIBEFRADIL;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; HYPOTENSION; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; WHITE COAT HYPERTENSION;

AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; MALE; MIBEFRADIL; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0036823452     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines subcommittee. J Hypert 1999; 17: 151-83.
2. Pickering TG, Coats A, Mallion JM, Mancia G, Verdecchia P. Blood pressure monitoring. Task force V: White-coat hypertension. Blood Press Monit 1999; 4: 333-41.
3. Veglio F, Rabbia F, Riva P, et al. Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension. Clin Exp Hypertens 2001; 23: 203-11.
4. Bainbridge AD, Herlihy O, Meredith PA, Elliott HL. A comparative assessment of amlodipine and felodipine ER: Pharmacokinetic and pharmacodynamic indices. Eur J Clin Pharmacol 1993; 45: 425-30.
5. Taylor SH, Chen MF, Lee S, et al. Efficacy and tolerability of amlodipine in general practice treatment of essential hypertension in an Asian multinational population. Clin Drug Invest 1998; 16: 177-85.
6. Hoegholm A, Wiinberg N, Rasmussen E, Nielsen PE. Comparative effects of amlodipine and felodipine ER on office and ambulatory blood pressure in patients with mild to moderate hypertension. Danish Multicentre Group. J Hum Hypertens 1995; 9 (Suppl) 1: 25-8.
7. Neaton JD, Grimm RH, Prineas RJ, et al. Treatment of mild hypertension study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA 1993; 270: 713-24.
8. Ostergren J, Isaksson H, Brodin U, Schwan A, Ohman KP. Effect of amlodipine versus felodipine extended release on 24-hour ambulatory blood pressure in hypertension. Am J Hypertens 1998; 11 (6 Pt 1): 690-6.
9. Zanetti-Elshater F, Pingitore R, Beretta-Piccoli C, Riesen W, Heinen G. Calcium antagonists for treatment of diabetes-associated hypertension. Metabolic and renal effects of amlodipine. Am J Hypertens 1994; 7: 36-45.
10. Mroczek WJ, Burris JF, Allenby KS. A double-blind evaluation of the effect of amlodipine on ambulatory blood pressure in hypertensive patients. J Cardiovasc Pharmacol 1988; 12 (Suppl 7): 79-84.
11. Hayduk K, Adamczak M. Initial Dose Titration of Amlodipine in Patients with Mild to Moderate Hypertension. Eur Heart J 1994; 15: 1101-6.
12. Velasco M, Hernandez R, Urbina A, Hernandez O, Guevara J. A double-blind, parallel, comparative evaluation of amlodipine against captopril in the monotherapeutic treatment of mild and moderate essential hypertension: Interim results. Postgrad Med J 1991; 67 (Suppl 5): 32-4.
13. Calvo C, Gude F, Abellan J, et al. A Comparative evaluation of amlodipine and hydrochlorothiazide as monotherapy in the treatment of isolated systolic hypertension in the elderly. Clin Drug Invest 2000; 19: 317-26.
14. Cheung BM, Lau CP, Wu BZ. Amlodipine, felodipine, and isradipine in the treatment of Chinese patients with mild-to-moderate hypertension. Clin Ther 1998; 20: 1159-69.
15. Tiebel R, Vahlbruch A, Stapff M. Efficacy, safety, and effects on hypertension-associated symptoms of losartan, alone or in combination with hydrochlorothiazide, versus amlodipine in patients with mild-to-moderate hypertension. Curr Ther Res 1998; 59: 325-40.
16. Oparil S, Barr E, Elkins M, Liss C, Vrecenak A, Edelman J. Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension. Clin Ther 1996; 18: 608-25.